Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particles
US11622935B2 · kind B2 · utility
1Cited by
105References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2022 |
| Grant date | Apr 11, 2023 |
| Priority date | — |
| Expiry date | Feb 16, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08L2312/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the treatment of ocular diseases in a human subject In particular, the invention relates to an intracameral administration of a sustained release biodegradable intracameral implant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.